| Frankfurt am Main, January 29, 2024| We are delighted and proud that the German Science and Humanities Council has today certified the Georg-Speyer-Haus in its press release "Impressive contributions to tumor research". "The GSH is characterized by a convincing research profile, excellent networking and a successful combination of preclinical and clinical research," explains Prof.… [mehr]

| Frankfurt am Main, November 15, 2023| Florian Greten, Director of the Georg-Speyer-Haus and speaker of the LOEWE Centre Frankfurt Cancer Institute is 2023 amongst the prestigious Highly Cited Researchers selected by Claviate (Web of Science). His work on colorectal cancers and especially the tumor microenvironment in the last decade had a major impact on… [mehr]

| Frankfurt am Main, November 10, 2023| The title of the approved research project is: "3D tumor-stroma models for the investigation of the phenotypic map in colorectal carcinoma". The project investigates how colorectal cancer cancers and their surrounding cells interact in the tumor microenvironment and where differences exist between individual tumors. In a cell culture… [mehr]

| Frankfurt am Main, August 2, 2023| Melek Canan Arkan is appointed to the W2 Professor for Tumor Metabolism from the LOEWE-Zentrum Frankfurt Cancer Institute at the Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus. She received her Ph.D. at the University of Turin, Italy and was a postdoctoral fellow at the University of California San… [mehr]

| Frankfurt am Main, January 29, 2023 – Researchers from the Georg-Speyer-Haus in Frankfurt am Main and the University Hospital and Goethe University Frankfurt, identified a new combination therapy to boost anti-tumor immune therapy in liver cancer and liver metastasis. Over the last decade, immune therapies have become part of the portfolio for the fight… [mehr]

Hesse’s LOEWE program for cancer research awards 18 million euros to Goethe University-led efforts – subsequently the aim is to continue as an independent institute | Frankfurt am Main, December 12, 2022 –  Due to its great success in cancer research, the LOEWE center "Frankfurt Cancer Institute" (FCI), which has been in existence since 2019,… [mehr]

Researchers in Frankfurt discover new mechanism of chemotherapy resistance in colon cancer | Frankfurt am Main, November 16, 2022 –   Researchers at Georg-Speyer-Haus and Goethe University Frankfurt have discovered a new mechanism that explains why only some of the cells in a colon tumour respond to chemotherapy. The research team led by Professor Florian… [mehr]

Researchers identify way to boost tumor-fighting immune cells | Frankfurt am Main, October 18, 2022 – Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Germany, were able to identify a new approach for the therapy of colorectal cancer (CRC) as part of an interdisciplinary project of the LOEWE Center Frankfurt Cancer Institute (FCI). In preclinical… [mehr]

#ScienceForUkraine – GSH supports initiative for scientists from Ukraine | Frankfurt am Main, March 08, 2022 – The Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy would be glad to host students as well as researchers (internships, bachelor and master theses, PhD, postdoctoral fellows, and associates) in fields of Life and Natural Sciences. We can… [mehr]

HR spotlights tumor research at Georg-Speyer-Haus on World Cancer Day | February 4 is World Cancer Day. To mark the occasion, the Hessischer Rundfunk took a closer look at Georg-Speyer-Haus. Why does radiation therapy work for one group of colorectal cancer patients and not for another? In fundamental research on tumor biology at GSH, researchers… [mehr]